IL-4/IL-13-dependent alternative activation of macrophages but not microglial cells is associated with uncontrolled cerebral cryptococcosis

American Journal of Pathology

Volumn 174, Issue 2, 2009, Pages 486-496

  Stenzel, Werner ^a   Müller, Uwe ^b   Köhler, Gabriele ^c   Heppner, Frank L ^a   Blessing, Manfred ^b   McKenzie, Andrew N J ^d   Brombacher, Frank ^e   Alber, Gottfried ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; BRAIN DAMAGE; BRAIN INFECTION; CELL ACTIVATION; CELL STRUCTURE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; MACROPHAGE; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 59649122244     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080598     Document Type: Article

References (66)

1. Mitchell TG, Perfect JR: Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995, 8:515-548
2. Lortholary O, Nunez H, Brauner MW, Dromer F: Pulmonary cryptococcosis. Semin Respir Crit Care Med 2004, 25:145-157
3. Malik R, Krockenberger MB, Cross G, Doneley R, Madill DN, Black D, McWhirter P, Rozenwax A, Rose K, Alley M, Forshaw D, Russell-Brown I, Johnstone AC, Martin P, O'Brien CR, Love DN: Avian cryptococcosis. Med Mycol 2003, 41:115-124
4. McAdams HP, Rosado-de-Christenson ML, Lesar M, Templeton PA, Moran CA: Thoracic mycoses from endemic fungi: radiologic-pathologic correlation. Radiographics 1995, 15:255-270
5. McAdams HP, Rosado-de-Christenson ML, Templeton PA, Lesar M, Moran CA: Thoracic mycoses from opportunistic fungi: radiologicpathologic correlation. Radiographics 1995, 15:271-286
6. Decken K, Kohler G, Palmer-Lehmann K, Wunderlin A, Mattner F, Magram J, Gately MK, Alber G: Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect Immun 1998, 66:4994-5000
7. Goldman D, Cho Y, Zhao M, Casadevall A, Lee SC: Expression of inducible nitric oxide synthase in rat pulmonary Cryptococcus neoformans granulomas. Am J Pathol 1996, 148:1275-1282
8. Huffnagle GB, Lipscomb MF, Lovchik JA, Hoag KA, Street NE: The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J Leukoc Biol 1994, 55:35-42
9. Retini C, Kozel TR, Pietrella D, Monari C, Bistoni F, Vecchiarelli A: Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans. Infect Immun 2001, 69:6064-6073
10. Chretien F, Lortholary O, Kansau I, Neuville S, Gray F, Dromer F: Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. J Infect Dis 2002, 186:522-530
11. Lortholary O, Improvisi L, Nicolas M, Provost F, Dupont B, Dromer F: Fungemia during murine cryptococcosis sheds some light on pathophysiology. Med Mycol 1999, 37:169-174
12. Olszewski MA, Huffnagle GB, McDonald RA, Lindell DM, Moore BB, Cook DN, Toews GB: The role of macrophage inflammatory protein-1 alpha/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection. J Immunol 2000, 165:6429-6436
13. Koguchi Y, Kawakami K: Cryptococcal infection and Th1-Th2 cytokine balance. Int Rev Immunol 2002, 21:423-438
14. McKenzie AN, Zurawski G: Interleukin-13: characterization and biologic properties. Cancer Treat Res 1995, 80:367-378
15. Blackstock R, Murphy JW: Role of interleukin-4 in resistance to Cryptococcus neoformans infection. Am J Respir Cell Mol Biol 2004, 30:109-117
16. Kawakami K, Hossain Qureshi M, Zhang T, Koguchi Y, Xie Q, Kurimoto M, Saito A: Interleukin-4 weakens host resistance to pulmonary and disseminated cryptococcal infection caused by combined treatment with interferon-gamma- inducing cytokines. Cell Immunol 1999, 197:55-61
17. Huffnagle GB, McNeil LK: Dissemination of C. neoformans to the central nervous system: role of chemokines. Th1 immunity and leukocyte recruitment. J Neurovirol 1999, 5:76-81
18. Arora S, Hernandez Y, Erb-Downward JR, McDonald RA, Toews GB, Huffnagle GB: Role of IFN-gamma in regulating T2 immunity and the development of alternatively activated macrophages during allergic bronchopulmonary mycosis. J Immunol 2005, 174:6346-6356
19. Müller U, Stenzel W, Köhler G, Werner C, Polte T, Hansen G, Schutze N, Straubinger RK, Blessing M, McKenzie AN, Brombacher F, Alber G: IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans. J Immunol 2007, 179:5367-5377
20. Nathan C, Shiloh MU: Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci USA 2000, 97:8841-8848
21. Stein M, Keshav S, Harris N, Gordon S: Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 1992, 176:287-292
22. Gordon S: Alternative activation of macrophages. Nat Rev Immunol 2003, 3:23-35
23. Mosser DM: The many faces of macrophage activation. J Leukoc Biol 2003, 73:209-212
24. Lumeng CN, Bodzin JL, Saltiel AR: Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007, 117:175-184
25. Lumeng CN, Deyoung SM, Bodzin JL, Saltiel AR: Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 2007, 56:16-23
26. Herbert DR, Holscher C, Mohrs M, Arendse B, Schwegmann A, Radwanska M, Leeto M, Kirsch R, Hall P, Mossmann H, Claussen B, Forster I, Brombacher F: Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 2004, 20:623-635
27. Pesce J, Kaviratne M, Ramalingam TR, Thompson RW, Urban JF, Jr., Cheever AW, Young DA, Collins M, Grusby MJ, Wynn TA: The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J Clin Invest 2006, 116:2044-2055
28. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, Nelson C, Lowman HB, Wright BD, Skelton NJ, Frantz GD, Tumas DB, Peale FV, Jr., Shelton DL, Hebert CC: FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 2000, 19:4046-4055
29. Hesse M, Modolell M, La Flamme AC, Schito M, Fuentes JM, Cheever AW, Pearce EJ, Wynn TA: Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J Immunol 2001, 167:6533-6544
30. Stutz AM, Pickart LA, Trifilieff A, Baumruker T, Prieschl-Strassmayr E, Woisetschlager M: The Th2 cell cytokines IL-4 and IL-13 regulate found in inflammatory zone 1/resistin-like molecule alpha gene expression by a STAT6 and CCAAT/enhancer-binding protein-dependent mechanism. J Immunol 2003, 170:1789-1796
31. Prasse A, Pechkovsky DV, Toews GB, Jungraithmayr W, Kollert F, Goldmann T, Vollmer E, Muller-Quernheim J, Zissel G: A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am J Respir Crit Care Med 2006, 173:781-792
32. Hölscher C, Arendse B, Schwegmann A, Myburgh E, Brombacher F: Impairment of alternative macrophage activation delays cutaneous leishmaniasis in nonhealing BALB/c mice. J Immunol 2006, 176:1115-1121
33. Mohrs M, Ledermann B, Köhler G, Dorfmuller A, Gessner A, Brombacher F: Differences between IL-4- and IL-4 receptor alpha-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling. J Immunol 1999, 162:7302-7308
34. Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H, Kohler G: Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993, 362:245-248
35. McKenzie GJ, Bancroft A, Grencis RK, McKenzie AN: A distinct role for interleukin-13 in Th2-cell-mediated immune responses. Curr Biol 1998, 8:339-342
36. Emson CL, Bell SE, Jones A, Wisden W, McKenzie AN: Interleukin (IL)-4-independent induction of immunoglobulin (Ig)E, and perturbation of T cell development in transgenic mice expressing IL-13. J Exp Med 1998, 188:399-404
37. Stenzel W, Soltek S, Miletic H, Hermann MM, Körner H, Sedgwick JD, Schluter D, Deckert M: An essential role for tumor necrosis factor in the formation of experimental murine Staphylococcus aureus-induced brain abscess and clearance. J Neuropathol Exp Neurol 2005, 64:27-36
38. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C[T]) Method. Methods 2001, 25:402-408
39. Ford AL, Goodsall AL, Hickey WF, Sedgwick JD: Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared. J Immunol 1995, 154:4309-4321
40. Stenzel W, Dahm J, Sanchez-Ruiz M, Miletic H, Hermann M, Courts C, Schwindt H, Utermöhlen O, Schluter D, Deckert M: Regulation of the inflammatory response to Staphylococcus aureus-induced brain abscess by interleukin-10. J Neuropathol Exp Neurol 2005, 64:1046-1057
41. Sedgwick JD, Ford AL, Foulcher E, Airriess R: Central nervous system microglial cell activation and proliferation follows direct interaction with tissue-infiltrating T cell blasts. J Immunol 1998, 160:5320-5330
42. Shao X, Mednick A, Alvarez M, van Rooijen N, Casadevall A, Goldman DL: An innate immune system cell is a major determinant of species-related susceptibility differences to fungal pneumonia. J Immunol 2005, 175:3244-3251
43. Maffei CM, Mirels LF, Sobel RA, Clemons KV, Stevens DA: Cytokine and inducible nitric oxide synthase mRNA expression during experimental murine cryptococcal meningoencephalitis. Infect Immun 2004, 72:2338-2349
44. Chen GH, Olszewski MA, McDonald RA, Wells JC, Paine R, 3rd, Huffnagle GB, Toews GB: Role of granulocyte macrophage colony-stimulating factor in host defense against pulmonary Cryptococcus neoformans infection during murine allergic bronchopulmonary mycosis. Am J Pathol 2007, 170:1028-1040
45. Milam JE, Herring-Palmer AC, Pandrangi R, McDonald RA, Huffnagle GB, Toews GB: Modulation of the Pulmonary T2 Response to Cryptococcus neoformans by Intratracheal Delivery of a TNF{alpha}-expressing Adenoviral Vector. Infect Immun 2007, 75:4951-4958
46. Blasi E, Barluzzi R, Mazzolla R, Mosci P, Bistoni F: Experimental model of intracerebral infection with Cryptococcus neoformans: roles of phagocytes and opsonization. Infect Immun 1992, 60:3682-3688
47. Goldman DL, Casadevall A, Cho Y, Lee SC: Cryptococcus neoformans meningitis in the rat. Lab Invest 1996, 75:759-770
48. Lee SC, Dickson DW, Casadevall A: Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implications. Hum Pathol 1996, 27:839-847
49. Babcock AA, Wirenfeldt M, Holm T, Nielsen HH, Dissing-Olesen L, Toft-Hansen H, Millward JM, Landmann R, Rivest S, Finsen B, Owens T: Toll-like receptor 2 signaling in response to brain injury: an innate bridge to neuroinflammation. J Neurosci 2006, 26:12826-12837
50. Ladeby R, Wirenfeldt M, Garcia-Ovejero D, Fenger C, Dissing-Olesen L, Dalmau I, Finsen B: Microglial cell population dynamics in the injured adult central nervous system. Brain Res Brain Res Rev 2005, 48:196-206
51. Nguyen MD, Julien JP, Rivest S: Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat Rev Neurosci 2002, 3:216-227
52. Stenzel W, Soltek S, Sanchez-Ruiz M, Akira S, Miletic H, Schluter D, Deckert M: Both TLR2 and TLR4 are required for the effective immune response in Staphylococcus aureus-induced experimental murine brain abscess. Am J Pathol 2008, 172:132-145
53. Hernandez Y, Arora S, Erb-Downward JR, McDonald RA, Toews GB, Huffnagle GB: Distinct roles for IL-4 and IL-10 in regulating T2 immunity during allergic bronchopulmonary mycosis. J Immunol 2005, 174:1027-1036
54. Kleinschek MA, Müller U, Brodie SJ, Stenzel W, Kohler G, Blumenschein WM, Straubinger RK, McClanahan T, Kastelein RA, Alber G: IL-23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL-12. J Immunol 2006, 176:1098-1106
55. Zhou Q, Gault RA, Kozel TR, Murphy WJ: Protection from direct cerebral cryptococcus infection by interferon-gamma-dependent activation of microglial cells. J Immunol 2007, 178:5753-5761
56. Uicker WC, Doyle HA, McCracken JP, Langlois M, Buchanan KL: Cytokine and chemokine expression in the central nervous system associated with protective cell-mediated immunity against Cryptococcus neoformans. Med Mycol 2005, 43:27-38
57. Lee SC, Kress Y, Zhao ML, Dickson DW, Casadevall A: Cryptococcus neoformans survive and replicate in human microglia. Lab Invest 1995, 73:871-879
58. Edwards JP, Zhang X, Frauwirth KA, Mosser DM: Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol 2006, 80:1298-1307
59. Taylor PR, Martinez-Pomares L, Stacey M, Lin HH, Brown GD, Gordon S: Macrophage receptors and immune recognition. Annu Rev Immunol 2005, 23:901-944
60. Alvarez M, Casadevall A: Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages. Curr Biol 2006, 16:2161-2165
61. Feldmesser M, Tucker S, Casadevall A: Intracellular parasitism of macrophages by Cryptococcus neoformans. Trends Microbiol 2001, 9:273-278
62. Tucker SC, Casadevall A: Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm. Proc Natl Acad Sci USA 2002, 99:3165-3170
63. Colton CA, Mott RT, Sharpe H, Xu Q, Van Nostrand WE, Vitek MP: Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflammation 2006, 3:27
64. Ponomarev ED, Maresz K, Tan Y, Dittel BN: CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J Neurosci 2007, 27:10714-10721
65. Dick AD, Ford AL, Forrester JV, Sedgwick JD: Flow cytometric identification of a minority population of MHC class II positive cells in the normal rat retina distinct from CD45lowCD11b/c+CD4low parenchymal microglia. Br J Ophthalmol 1995, 79:834-840
66. Shibuya K, Hirata A, Omuta J, Sugamata M, Katori S, Saito N, Murata N, Morita A, Takahashi K, Hasegawa C, Mitsuda A, Hatori T, Nonaka H: Granuloma and cryptococcosis. J Infect Chemother 2005, 11:115-122